280E Updates: Rescheduling, Amending Returns, and Why Timing Matters - Sign up for our free webinar now!
280E Updates: Rescheduling, Amending Returns, and Why Timing Matters - Sign up for our free webinar now!
Thomas Skovlund Schnegelsberg, STENOCARE | Cannabis Business Times
Continue to Site »
Site will load in 15 seconds

Thomas Skovlund Schnegelsberg, STENOCARE

Thomas Skovlund Schnegelsberg

Thomas Skovlund Schnegelsberg is the co-founder and CEO of STENOCARE, a publicly traded Danish company that supplies prescription-based medical cannabis oils to patients in the European and Australian markets.

From Thomas Skovlund Schnegelsberg, STENOCARE
Columns
Innovating for the Benefit of Patients in Medical Cannabis (Opinion)
Poor bioavailability formulations in orally delivered medical cannabis have left an innovation gap for patients.
April 28, 2025
Stenocare 365250395
Page 1 of 1